Joint Meeting of the Coverage and Future Vaccines Subcommittees October 5, 2004

Joint Meeting of the Coverage and Future Vaccines Subcommittees October 5, 2004  Rationale: – in view of future vaccines being developed for use in adolescents, there are concerns about the capacity to reach and immunize the majority of adolescents  Purpose: – Seek comment and collaboration in the planning of a National Stakeholder Meeting on Strategies to Increase the Uptake of New Vaccines for Adolescents

Future Vaccines  MCV  Tdap  HPV  HSV  CMV  HIV

Previous NVAC Efforts in Adolescent Immunization  Adolescent Immunization Workshop  1996 – Summary Report of Workshop on Adolescent Immunization – Recommendations not implemented due to lack of identifiable resources  1996 – MMWR publication “Immunization of Adolescents”

Summary of NFID Meeting on Adolescent Immunization, 8/04  Roundtable discussion of issues and strategies chaired by Dr. W. Schaffner – Identification of barriers – Identify best practices and successful model programs – School based requirements – Public education and awareness – Vaccine cost – Partnerships

Summary of NFID Meeting on Adolescent Immunization  NFID Monograph to be published on the Roundtable discussion of exploration and awareness of issues surrounding adolescent immunization

Adolescent Stakeholders Meeting Goals  Identify the strengths and weaknesses of key implementation strategies and issues  Identify approaches that will effectively and efficiently increase the proportion of adolescents who receive vaccines  Develop plans to implement these approaches  Identify research initiatives – Support the successful introduction – Accelerate development of vaccines in the 'pipeline'

Adolescent Stakeholders Meeting Key Strategies and Issues Delivery systems and settings Communications strategies Research initiatives for future vaccines Integration with other adolescent health priorities Financing and other important barriers

Adolescent Stakeholders Meeting Key Strategies and Issues Immunization regulations and other mandates Consent Appropriate roles and responsibilities (local, state, and federal) Novel vaccine delivery systems

Key Strategy Delivery Systems and Settings Key Strategy Delivery Systems and Settings  In which combination of delivery systems and settings can the new adolescent vaccines best be implemented? – In the medical home – Outside the medical home – Non-traditional settings – Schools

Key Strategy Communication Strategies  What communications strategies are most appropriate and effective? – How should parents be informed? – How should patients be informed? – How should providers be informed?

Key Strategy Research Initiatives  What should the research agenda be for future vaccines for adolescents?  What is the role of novel vaccine delivery systems (i.e., needle-less systems) for delivery of vaccines to adolescents?

Key Strategy Integration with other Adolescent Health Priorities  How can vaccination be integrated with other adolescent health priorities? – Anticipatory guidance – Injury prevention – Prevention of drug and alcohol use

Key Strategy Vaccine Financing  How should adolescent vaccination efforts be financed? – Identification of resources

Key Strategy Immunization regulations and other mandates  When and how should immunization regulations and other mandates be used to increase the uptake of new vaccines?

Key Strategy Consent Issues  Are there new approaches to obtaining consent? – What laws enable minors to consent to treatment and prevention services in the U.S.? – What is the current and potential use of these laws to enable self-consent for adolescent immunization? – Can a single consent be flexible, e.g. covering multiple vaccinations with a single consent form?

Key Strategy Barriers  What are the barriers?  Which other barriers are most important to the health care system, providers, and patients? – e.g. missed opportunities, lack of knowledge (patients and providers), cost

Adolescent Stakeholders Meeting Key Strategy  What are the appropriate roles and responsibilities of local, state, and federal public health officials?

List of Stakeholders  Provider organizations, ie AAP, SAM, AAFP, AMA, NMA, ANA, etc.  Non-pediatric provider organizations – ACOG, STD Clinics, etc..  NGO’s  Vaccine manufacturers  Federal, local and state public health agencies

Stakeholder Meeting  Venue: Washington DC  Time: June 2005  Duration: 2 day meeting

Stakeholder Meeting Organizing Committee  TBA; volunteers needed  Consider a CoSponsor for the meeting, i.e. SAM  Include adolescent specialists from SAM, AAP, ACIP, CDC, etc..